tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
PremiumCompany AnnouncementsLexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
24d ago
Lexaria Bioscience achieves primary endpoint in Phase 1b study GLP-1-H24-4
Premium
The Fly
Lexaria Bioscience achieves primary endpoint in Phase 1b study GLP-1-H24-4
24d ago
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
Premium
Company Announcements
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
1M ago
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents
PremiumCompany AnnouncementsLexaria Bioscience Expands Strategic Outreach and Secures New Patents
3M ago
Lexaria Bioscience engages advisory firm to identify new business opportunities
Premium
The Fly
Lexaria Bioscience engages advisory firm to identify new business opportunities
3M ago
Lexaria Bioscience Secures $4 Million for R&D Expansion
Premium
Company Announcements
Lexaria Bioscience Secures $4 Million for R&D Expansion
4M ago
Lexaria Bioscience to Present at H.C. Wainwright Global Investment Conference
PremiumCompany AnnouncementsLexaria Bioscience to Present at H.C. Wainwright Global Investment Conference
5M ago
Lexaria Bioscience Completes Key Phase 1b Study Milestone
Premium
Company Announcements
Lexaria Bioscience Completes Key Phase 1b Study Milestone
5M ago
Lexaria Bioscience study achieves last patient last visit milestone
Premium
The Fly
Lexaria Bioscience study achieves last patient last visit milestone
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100